Abstract
The natural process of endochondral bone formation in the growing skeletal system is increasingly inspiring the field of bone tissue engineering. However, in order to create relevant-size bone grafts, a cell carrier is required that ensures a high diffusion rate and facilitates matrix formation, balanced by its degradation. Therefore, we set out to engineer endochondral bone in gelatin methacrylamide (GelMA) hydrogels with embedded multipotent stromal cells (MSCs) and cartilage-derived matrix (CDM) particles. CDM particles were found to stimulate the formation of a cartilage template by MSCs in the GelMA hydrogel in vitro. In a subcutaneous rat model, this template was subsequently remodeled into mineralized bone tissue, including bone-marrow cavities. The GelMA was almost fully degraded during this process. There was no significant difference in the degree of calcification in GelMA with or without CDM particles: 42.5 +/- 2.5% vs. 39.5 +/- 8.3% (mean +/- standard deviation), respectively. Interestingly, in an osteochondral setting, the presence of chondrocytes in one half of the constructs fully impeded bone formation in the other half by MSCs. This work offers a new avenue for the engineering of relevant-size bone grafts, by the formation of endochondral bone within a degradable hydrogel. (C) 2014 Elsevier Ltd. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 174-182 |
Number of pages | 9 |
Journal | Biomaterials |
Volume | 37 |
DOIs | |
Publication status | Published - Jan 2015 |
Funding
The authors would like to thank Kristel Boere for her assistance with the mechanical testing and Mattie van Rijen for his assistance in fluorescent microscope imaging. The antibody against collagen type II (II-II6B3), developed by T.F Linsenmayer, was obtained from the DSHB developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. Jetze Visser was supported by a grant from the Dutch Government to the Netherlands Institute for Regenerative Medicine (NIRM, grant no FES0908); DG was supported by a VENI Fellowship (11208) from the Dutch Technology Foundation, STW, Applied Science Division of NWO and the Technology Program of the Ministry of Economic Affairs. Kim Benders received an Alexandre Suerman Stipendium from the University Medical Center Utrecht and Jos Malda was supported by the Dutch Arthritis Foundation.
Keywords
- Tissue engineering
- Regeneration
- Rat
- Decellularized matrix
- GelMA
- MESENCHYMAL STEM-CELLS
- TISSUE-ENGINEERED CONSTRUCTS
- MULTIPOTENT STROMAL CELLS
- EXTRACELLULAR-MATRIX
- REGENERATIVE MEDICINE
- OXYGEN-TENSION
- GROWTH-PLATE
- ADULT HUMAN
- OSSIFICATION
- CHONDROGENESIS